Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery
Open Access
- 20 May 2009
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 301 (19) , 1991-1996
- https://doi.org/10.1001/jama.2009.683
Abstract
Benign prostatic hyperplasia (BPH) affects nearly 3 out of 4 men by the age of 70 years.1,2 Medical management of BPH is often preferred to surgical treatment because surgery increases the risk of impotence and incontinence. An effective and commonly prescribed medication for BPH is tamsulosin,3 which accounted for more than $1 billion in sales in 2007.4Keywords
This publication has 36 references indexed in Scilit:
- Urologic Diseases in America Project: Benign Prostatic HyperplasiaJournal of Urology, 2008
- Clinical Features, Complications, and Incidence of Intraoperative Floppy Iris Syndrome in Patients Taking TamsulosinEuropean Journal of Ophthalmology, 2007
- Intraoperative floppy-iris syndrome during cataract surgery in men using alpha-blockers for benign prostatic hypertrophyJournal of Cataract & Refractive Surgery, 2007
- Incidence of Intraoperative Floppy Iris Syndrome in Patients on Either Systemic or Topical α1-Adrenoceptor AntagonistAmerican Journal of Ophthalmology, 2007
- Prospective Multicenter Evaluation of Cataract Surgery in Patients Taking Tamsulosin (Flomax)Ophthalmology, 2007
- Incidence of Intraoperative Floppy Iris Syndrome in Patients on Either Systemic or Topical α1-Adrenoceptor AntagonistAmerican Journal of Ophthalmology, 2007
- Floppy iris behaviour during cataract surgery: associations and variationsBritish Journal of Ophthalmology, 2006
- Prevalence and clinical findings of tamsulosin-associated intraoperative floppy-iris syndromeJournal of Cataract & Refractive Surgery, 2006
- Intraoperative floppy iris syndrome associated with tamsulosinJournal of Cataract & Refractive Surgery, 2005
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003